120 related articles for article (PubMed ID: 7540211)
1. Ranking potential binding peptides to MHC molecules by a computational threading approach.
Altuvia Y; Schueler O; Margalit H
J Mol Biol; 1995 Jun; 249(2):244-50. PubMed ID: 7540211
[TBL] [Abstract][Full Text] [Related]
2. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
Schiewe AJ; Haworth IS
J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
[TBL] [Abstract][Full Text] [Related]
3. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
4. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
5. Five viral peptide-HLA-A2 co-crystals. Simultaneous space group determination and X-ray data collection.
Garboczi DN; Madden DR; Wiley DC
J Mol Biol; 1994 Jun; 239(4):581-7. PubMed ID: 7516439
[TBL] [Abstract][Full Text] [Related]
6. Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
[TBL] [Abstract][Full Text] [Related]
7. A structure-based approach for prediction of MHC-binding peptides.
Altuvia Y; Margalit H
Methods; 2004 Dec; 34(4):454-9. PubMed ID: 15542371
[TBL] [Abstract][Full Text] [Related]
8. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
9. Predicting peptide binding to Major Histocompatibility Complex molecules.
Liao WW; Arthur JW
Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
[TBL] [Abstract][Full Text] [Related]
10. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes.
Sudo T; Kamikawaji N; Kimura A; Date Y; Savoie CJ; Nakashima H; Furuichi E; Kuhara S; Sasazuki T
J Immunol; 1995 Nov; 155(10):4749-56. PubMed ID: 7594476
[TBL] [Abstract][Full Text] [Related]
11. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
[TBL] [Abstract][Full Text] [Related]
12. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
Bordner AJ; Abagyan R
Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
[TBL] [Abstract][Full Text] [Related]
13. Ranking of binding and nonbinding peptides to MHC class I molecules using inverse folding approach: implications for vaccine design.
Singh SP; Mishra BN
Bioinformation; 2008; 3(2):72-82. PubMed ID: 19238199
[TBL] [Abstract][Full Text] [Related]
14. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
15. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
Parker KC; Bednarek MA; Coligan JE
J Immunol; 1994 Jan; 152(1):163-75. PubMed ID: 8254189
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
17. Structure-based identification of MHC binding peptides: Benchmarking of prediction accuracy.
Kumar N; Mohanty D
Mol Biosyst; 2010 Dec; 6(12):2508-20. PubMed ID: 20953500
[TBL] [Abstract][Full Text] [Related]
18. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
[TBL] [Abstract][Full Text] [Related]
19. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2.
Garboczi DN; Utz U; Ghosh P; Seth A; Kim J; VanTienhoven EA; Biddison WE; Wiley DC
J Immunol; 1996 Dec; 157(12):5403-10. PubMed ID: 8955188
[TBL] [Abstract][Full Text] [Related]
20. Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.
Poenaru S; Lamas JR; Folkers G; López de Castro JA; Seebach D; Rognan D
J Med Chem; 1999 Jul; 42(13):2318-31. PubMed ID: 10395472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
